2238 Tuluc, Madalina - Thomas Jefferson University - Thomas Jefferson University
mxt028

Madalina Tuluc, MD, PhD

Contact Dr. Tuluc

132 South 10th Street
285R Main
Philadelphia, PA 19107

(215) 955-7524
(215) 923-1969 fax

Most Recent Peer-reviewed Publications

  1. Ciliated Adenosquamous Carcinoma: Expanding the Phenotypic Diversity of Human Papillomavirus-Associated Tumors
  2. Aging effects on pedicled fasciocutaneous flap survival in rats
  3. Malignant Sarcomatous Transformation of Fibrous Dysplasia
  4. A Rare Case of Carcinoma Cuniculatum Involving the Larynx in Association with a Saccular Cyst
  5. Orbital involvement by NUt midline carcinoma
  6. Parathyroid Hormone-Related Peptide-Linked Hypercalcemia in a Melanoma Patient Treated with Ipilimumab: Hormone Source and Clinical and Metabolic Correlates
  7. Salivary duct carcinoma: The predominance of apocrine morphology, prevalence of histologic variants, and androgen receptor expression
  8. Mitochondrial Metabolism as a Treatment Target in Anaplastic Thyroid Cancer
  9. Multicompartment metabolism in papillary thyroid cancer
  10. Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-Analysis
  11. Malignant Sarcomatous Transformation of Fibrous Dysplasia
  12. Thyroid Cytology
  13. Recurrent epistaxis and nasal congestion
  14. Chondrosarcoma of the hyoid bone: Case report and review of current management options
  15. Tumor microenvironment in head and neck squamous cell carcinoma
  16. False-positive fna due to highly sensitive braf assay
  17. Current management of locally advanced head and neck cancer: The combination of chemotherapy with locoregional treatments
  18. Combination of p16 levels and pre-radiotherapy factors predicts outcome in patients treated for oropharyngeal carcinoma
  19. Fibroblast growth factor-2 (FGF2) and syndecan-1 (SDC1) are potential biomarkers for putative circulating CD15+/CD30+ cells in poor outcome Hodgkin lymphoma patients
  20. Oncogenes and inflammation rewire host energy metabolism in the tumor microenvironment RAS and NFκB target stromal MCT4
0